Direct-to-consumer prescription drug advertising: understanding its consequences

References

• Aaker, D.A. & Myers, J.G. (1975) Advertising Management. Englewood Cliffs, NJ: Prentice-Hall.
   Google Scholar
• Alperstein, N.M. & Peyrot, M. (1993) Consumer awareness of prescription drug advertising. Journal of Advertising Research, 33(4), pp. 50–56.
   Google Scholar
• Balazs, A.L., Yermolovich, J. & Zinkhan, G.M. (2000) Direct to consumer advertising: an ad processing perspective. Marketing in a Global Economy Proceedings.
   Google Scholar
• Blankenhorn, K. & Lipson, D. (2002) Business watch, 2001 in review: despite economic challenges, pharmaceutical industry still maintains steady growth. Medical Marketing & Media, 37, May, pp. 46–62.
   Google Scholar
• Calfee, J.E. (2002) Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy & Marketing, 21(2), pp. 174–193.
   Google Scholar
• Colley, R. (1961) Defining Advertising Goals for Measured Advertising Results. New York: Association of National Advertisers.
   Google Scholar
• Davis, J.J. (2000) Riskier than we think? The relationship between risk statement completeness and perceptions of direct consumer advertised prescription drugs. Journal of Health Communication, 5(4), pp. 349–369.
   Google Scholar
• Findlay, S.D. (2001) Direct-to-consumer promotion of prescription drugs: economic implications for patients, payers and providers. Pharmacoeconomics, 19(2), pp. 109–119.
   Google Scholar
• Harris, R.J. (1983) Information Processing Research in Advertising. Hillsdale, NJ: Lawrence Erlbaum Associates, p. 8.
   Google Scholar
• Hollon, M.F. (1999) Direct-to-consumer marketing of prescription drugs: creating consumer demand. The Journal of the American Medical Association, 281(4), p. 382.
   Google Scholar
• Holtz, W.E. (1998) Consumer-directed prescription drug advertising: effects on public health. Journal of Law and Health, 13(2), pp. 199–218.
   Google Scholar
• Kaiser Family Foundation (2001) Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising. Menlo Park, CA, November.
   Google Scholar
• Lavidge, R.J. & Steiner, G.A. (1961) A model for predictive measurements of advertising effectiveness. Journal of Marketing, 25(6), pp. 59–62.
   Google Scholar
• Lexchin, J. & Mintzes, B. (2002) Direct-to-consumer advertising of prescription drugs: the evidence says no. Journal of Public Policy & Marketing, 21(2), pp. 194–201.
   Google Scholar
• MacKenzie, S.B. & Lutz, R.J. (1989) An empirical examination of the structural antecedents of attitude toward the ad in an advertising pretesting context. Journal of Marketing, 53, April, pp. 48–65.
   Google Scholar
• McGuire, W.J. (1978) An information processing model of advertising effectiveness. In: Davis, H.L. & Silk, A.J. (eds) Behavioral and Management Science in Marketing. New York: Ronald Press.
   Google Scholar
• McInturff, B. (2001) Consumers see benefit in what they see, read. Advertising Age, 26 March, p. 24.
   Google Scholar
• Perri, M. III & Nelson, A.A. Jr (1987) An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription medications. Journal of Health Care Marketing, 7(1), pp. 9–17.
   Google Scholar
• Perri, M.W. & Dickson, M. (1988) Consumer reaction to a direct-to-consumer prescription drug advertising campaign. Journal of Health Care Marketing, 8(2), pp. 66–69.
   Google Scholar
• Peyrot, M., Alperstein, N.M., Doren, D.V. & Poli, L.G. (1998) Direct-to-consumer ads can influence behavior. Marketing Health Services, Summer, 18(2), pp. 26–32.
   Google Scholar
• Pfizer, Inc. (2001) Direct-to-Consumer Advertising: How it Benefits Consumers, June. Rogers, A. (1986) Prescription drug ads still cloudy. Adweek, 28 April.
   Google Scholar
• Sengupta, S. (2002) Prescription drug advertising: the effectiveness of pitching directly to consumers. Association for Education in Journalism and Mass Communication Conference.
   Google Scholar
• Siegel, L. (2000) DTC advertising: bane … or blessing? A 360-degree view. Pharmaceutical Executive, 20(10), pp. 140–152.
   Google Scholar
• US General Accounting Office (2003) Prescription Drugs: FDA Oversight of Direct-to- Consumer Drug Advertising Has Limitations, pp. 3–5.
   Google Scholar
• West, D. (2005) Changing lanes. Pharmaceutical Executive, 25(5), pp. 154–159.
   Google Scholar
• Wilkes, M.S., Bell, R.A. & Kravitz, R.L. (2000) Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs, 19(2), pp. 110–128.
   Google Scholar
• Williams, J.R. & Hensel, P.J. (1995) Direct-to-consumer advertising of prescription drugs. Journal of Health Care Marketing, 15(1), pp. 35–41.
   Google Scholar